<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02480543</url>
  </required_header>
  <id_info>
    <org_study_id>0085-15-WOMC</org_study_id>
    <nct_id>NCT02480543</nct_id>
  </id_info>
  <brief_title>Different Routes of Misoprostol Prior to First Trimester Surgical Abortion</brief_title>
  <official_title>Different Routes of Misoprostol for Same-day Cervical Preparation Prior to First Trimester Surgical Abortion: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wolfson Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wolfson Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized clinical trial to assess the effectiveness of same-day cervical preparation with
      oral, buccal or vaginal Misoprostol, given 2-4 hours prior first trimester curettage.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Preoperative cervical width in centimeters</measure>
    <time_frame>intraoperative</time_frame>
    <description>â€¢ Initial cervical dilatation assessed by performing cervical dilatation , beginning with a number 10 Hegar dilator and subsequently inserting smaller Hegar dilators until the dilator can pass through the internal os without resistance. The largest one to pass will consist the initial cervical width.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time required to achieve cervical dilatation</measure>
    <time_frame>intraoperative</time_frame>
    <description>The time in minutes required for dilatation up to a number 10 Hegar</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ease of cervical dilatation</measure>
    <time_frame>intraoperative</time_frame>
    <description>The subjective ease of cervical dilatation recorded by the surgeon on a 5-point Likert scale (1-very difficult, 5- very easy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient preference</measure>
    <time_frame>baseline</time_frame>
    <description>Patient acceptability of the administration of medication on a 5-point Likert scale (1-very uncomfortable, 5-very comfortable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effects of medication</measure>
    <time_frame>baseline</time_frame>
    <description>Self reported misoprostol-associated adverse effects before the procedure (such as nausea, vomiting)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical complications</measure>
    <time_frame>intraoperative</time_frame>
    <description>Complications arising during surgery (perforation, cervical laceration, excess bleeding)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Abortion, Induced</condition>
  <arm_group>
    <arm_group_label>PO Misoprostol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cervical preparation with per-os (PO) Misoprostol 400 mcg 2-4 hours prior to curettage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PV Misoprostol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cervical preparation with per-vagina (PV) Misoprostol 400 mcg 2-4 hours prior to curettage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Buccal Misoprostol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cervical preparation with buccal Misoprostol 400 mcg 2-4 hours prior to curettage</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol (cytotec)</intervention_name>
    <arm_group_label>PO Misoprostol</arm_group_label>
    <arm_group_label>PV Misoprostol</arm_group_label>
    <arm_group_label>Buccal Misoprostol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients admitted for elective first trimester abortion (termination of pregnancy/
             missed abortion) at Wolfson Medical Center, gestational age &lt;13+0 weeks

          -  Written consent supplied

        Exclusion Criteria:

          -  Contraindications to prostaglandin treatment (severe asthma, glaucoma, severe cardiac
             disease, renal failure)

          -  Prostaglandin allergy

          -  Genital infection

          -  Space-occupying lesion in the endocervical canal

          -  Prior cervical surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hadas Ganer Herman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Edith Wolfson Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hadas Ganer Herman, MD</last_name>
    <phone>972-077-2066960</phone>
    <email>hadassganer@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Edith Wolfson Medical Center</name>
      <address>
        <city>Holon</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hadas Ganer Herman, MD</last_name>
      <phone>972526206696</phone>
      <email>hadassganer@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2015</study_first_submitted>
  <study_first_submitted_qc>June 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2015</study_first_posted>
  <last_update_submitted>April 28, 2016</last_update_submitted>
  <last_update_submitted_qc>April 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wolfson Medical Center</investigator_affiliation>
    <investigator_full_name>Hadas Ganer Herman</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>November 8, 2016</submitted>
    <returned>January 5, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

